The Rationale for Use of Incretins in the Management of New Onset Diabetes after Transplantation (nodat).

@article{Sadhu2015TheRF,
  title={The Rationale for Use of Incretins in the Management of New Onset Diabetes after Transplantation (nodat).},
  author={Archana Reddy Sadhu and Stanley S. Schwartz and Mary E Herman},
  journal={Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists},
  year={2015},
  volume={21 7},
  pages={814-22}
}
OBJECTIVE Owing to advances in transplant science, increasing numbers of patients are receiving solid organ transplantation. New onset diabetes after transplantation (NODAT) frequently develops in transplant patients and requires acute and often ongoing management of hyperglycemia. The metabolic derangements of NODAT are similar to those of classic type 2… CONTINUE READING